Navigation Links
Journal of Clinical Oncology Publishes Phase 2 Clinical Trial Results of KRX-0401 (Perifosine) Plus Capecitabine in Patients with Metastatic Colorectal Cancer
Date:10/5/2011

NEW YORK, Oct. 5, 2011 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) (the "Company") today announced that a manuscript entitled "Randomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine as Second- or Third-Line Therapy in Patients with Metastatic Colorectal Cancer" reporting Phase 2 activity of KRX-0401 (perifosine) in the treatment of patients with refractory, advanced colorectal cancer (mCRC), was selected for publication in the October 3, 2011 online edition of the Journal of Clinical Oncology (JCO).  Perifosine, the Company's novel, potentially first-in-class, oral anti-cancer drug candidate that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, is currently being investigated in a Phase 3 trial entitled the "X-PECT" (Xeloda® + Perifosine Evaluation in Colorectal cancer Treatment),which is a randomized (1:1), double-blind trial comparing the efficacy and safety of perifosine + capecitabine vs. placebo + capecitabine. The Phase 3 X-PECT study is being conducted under a Special Protocol Assessment (SPA), and with Fast Track designation.  In July, the Company announced the completion of enrollment into the Phase 3 X-PECT study, with approximately 465 patients in the United States randomized. Approximately 360 events of death will trigger the un-blinding of the study.  Study completion is expected in 1Q 2012.

The JCO publication highlights the efficacy and safety data on the 38 mCRC patients participating in this Phase 2, randomized, multicenter study, comparing perifosine plus capecitabine (P-CAP) to placebo plus capecitabine.  Based on the data, in which the combination of P-CAP demonstrated statistical significance with respect to median overall survival and median time to tumor progression, the investigators concluded that the P-CAP combination showed promising clinical activity co
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Atrium Announces the Publication of the COBEST Trial by the Journal of Vascular Surgery
2. Telik Announces Publication in the Journal Cancer of a Phase 2 Randomized Multicenter Study of Two Extended Dosing Schedules of Oral Ezatiostat in Low to Intermediate-1 Risk Myelodysplastic Syndrome
3. eCardio Among Honorees of the Houston Business Journals Fast 100 List for Second Consecutive Year
4. Elsevier Launches European Journal of Cancer iPad Edition
5. Results of a Pivotal Phase 3 Efficacy and Safety Study for Butrans® (Buprenorphine) Transdermal System CIII Published in The Journal of Pain
6. NxStage: NIH Study Published in New England Journal of Medicine Adds to Growing Body of Evidence in Support of More Frequent Hemodialysis
7. New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis
8. Zertane™ Clinical Results Published in the Journal European Urology
9. Lexicon Announces Publication of Results From the Phase 2 Trial of LX1031 in Patients With Irritable Bowel Syndrome in Journal of Gastroenterology
10. Cornerstone Pharmaceuticals Announces The Journal of Molecular Medicines Publication of Research Showing Selective Inhibition of Cancer Cell Energy Metabolism With Its Novel Lipoate Derivative Compounds
11. Study Published in Journal of Vascular Surgery Confirms Superiority of Artegraft BCA to Cuffed ePTFE for Hemodialysis Access
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 26, 2015 Zimmer Holdings, Inc. (NYSE and ... Advanced Bearing Technology with Vitamin E by celebrating ... earlier this month reported that, at 96 million cycles ... Bearing Technology featuring Vitamin E grafted highly crosslinked polyethylene ... rate reduction of 95 percent, with no cracking, delamination ...
(Date:3/26/2015)... , March 26, 2015 Even the Score ... the Food and Drug Administration,s landmark approval of Viagra ... members of Congress calling on the Agency to begin ... first-ever medical treatment for women,s most common sexual dysfunction. ... medical treatment options for sexual dysfunction – while women ...
(Date:3/26/2015)... According to a new ... Market by Functionality (Adverse Event Reporting, Fully Integrated Software), ... & Biotech Companies, CROs, BPOs) - Global Forecast ... Drug Safety Software Market is poised to grow ... is expected to reach a value of $154.1 ...
Breaking Medicine Technology:Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 2Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 3Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 4Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 2Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 3Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 4
... Vantage Health (OTC BB: VNTH), ("Vantage"), ("company") announced today ... officials from the Ministry of Health and Social Welfare, ... all representing the United Republic of Tanzania ("URT") which ... formal Public Private Partnership ("PPP") Agreement between Vantage, its ...
... 2011 AAPC Physician Services ( www.aapcps.com ) recently ... to help busy medical practices simplify adherence to ... physician practice setting we are bombarded with compliance issues ... Schwebach, VP of AAPC Physician Services. "This compliance toolkit ...
Cached Medicine Technology:Tanzania Minister of Health, on Behalf of the Government, Promises Full Support to Vantage Health in the United Republic of Tanzania 2Tanzania Minister of Health, on Behalf of the Government, Promises Full Support to Vantage Health in the United Republic of Tanzania 3Tanzania Minister of Health, on Behalf of the Government, Promises Full Support to Vantage Health in the United Republic of Tanzania 4
(Date:3/27/2015)... March 27, 2015 In light of ... number 1:15-cv-10429, U.S. District Court, District of Massachusetts; and ... Eastern District of Pennsylvania), the San Diego personal injury ... A.P.C. are announcing that they are available to investigate ... women who were prescribed Zofran while pregnant and who ...
(Date:3/26/2015)... Dallas, TX (PRWEB) March 26, 2015 ... of the 32nd annual Dallas Rhinoplasty Symposium and ... the years, reiterated the importance of evidence based medicine ... utilizing evidence from well conducted research. , "We often ... approaches to rhinoplasty, and while we are certainly not ...
(Date:3/26/2015)... Florida Hospital teamed up with ABC Action News to ... live Dr. Oz event, which took place at the Westfield ... thousand people came out to see Dr. Mehmet Oz and ... renowned cardiothoracic surgeon and Emmy award winning talk show host ... of experts for the live health expo. Florida Hospital physicians, ...
(Date:3/26/2015)... Old Tappan, NJ (PRWEB) March 26, 2015 ... research and statistical consulting firm, announced the release of ... by health experts to increase access to public restrooms ... recent trends in bathroom apps, BathroomMap does not facilitate ... a proprietary algorithm to identify and rate local establishments ...
(Date:3/26/2015)... 26, 2015 Dr. Alex Rabinovich and ... announce expanded offerings for Bay Area patients considering dental ... Center has long been a top-rated center, serving primarily ... to meet the strong demand by others throughout Northern ... a top-rated dental implant facility in San Francisco,”explained Dr. ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock, A.P.C. Announces That It Is Now Accepting Case Reviews for Potential Zofran Birth Defect Lawsuits 2Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 2Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 3Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3
... By Alan Mozes HealthDay Reporter , THURSDAY, March ... your computer hour after hour may well have its benefits, ... dry, tired eyes, blurred vision, fatigue and headaches. This ... eye experts don,t agree on whether it,s serious or even ...
... Sevan Goenezen holds the promise of becoming a powerful ... complex computational research has led to a fast, inexpensive ... differentiate between benign and malignant tumors with a high ... Department of Mechanical, Aerospace, and Nuclear Engineering at Rensselaer, ...
... March 3, 2011 Men living in low-income neighbourhoods consume ... compared to women in these neighbourhoods, according to a study ... findings, published in the Journal of Epidemiology and Community ... when it comes to alcohol consumption. Heavy drinking is associated ...
... March 3, 2010 Elsevier / Gold Standard, a ... announced today several enhancements to its pricing tool, ProspectoRx, ... to facilitate pricing analysis. The rate and ... environment make current, accurate and easily accessible pricing information ...
... By Serena Gordon HealthDay Reporter , WEDNESDAY, March ... people with both type 2 diabetes and heart disease -- ... maintain the blood sugar levels typical of people without diabetes ... 2 diabetes and heart disease by 19 percent, according to ...
... March 3, 2011 Patients with end-stage renal disease who ... infection than those who undergo hemodialysis, a retrospective study at ... is less costly, easier on the body and provides greater ... "Patients actually survive better on peritoneal dialysis, have a ...
Cached Medicine News:Health News:Computer Vision Syndrome: Fact or Fiction? 2Health News:Computer Vision Syndrome: Fact or Fiction? 3Health News:Student innovation at Rensselaer Polytechnic Institute could lead to better breast cancer screening 2Health News:Student innovation at Rensselaer Polytechnic Institute could lead to better breast cancer screening 3Health News:Men in low income neighborhoods drink more than women: Study 2Health News:Tight Blood Sugar Control May Put Some Diabetics at Risk 2Health News:Tight Blood Sugar Control May Put Some Diabetics at Risk 3Health News:Portable, less costly peritoneal dialysis shows no additional catheter risk factors 2
... III Model 8042 increases therapy versatility ... to optimize sensing, pacing and cardiac ... offers unmatched insight through key heart ... efficiently track a patient's clinical status. ...
... The OTI-Scan 3D is ... ultrasound system available today. ... B and A-scan system ... Macintosh desktop or laptop ...
... is an extremely accurate digital A-scan system. ... noise probe and fast precise algorithm enables ... probe along the visual axis. The A5500 ... CRT monitor, built-in thermal printer, 5 different ...
... advanced IOL workstation. Accurate, efficient and easy ... used with a variety of regressive, theoretical, ... the needs of the patient. Convenient design ... foot pedal for hands-free operation, audible tone ...
Medicine Products: